We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RDNT market cap is 4.54B. The company's latest EPS is USD 0.0411 and P/E is 1491.97.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 418.78M | 420.38M | 431.71M | 459.71M | 461.14M |
| Operating Income | 44.86M | 27.83M | 15.85M | 38.64M | 37.65M |
| Net Income | 17.54M | -1.86M | -2.78M | -2.98M | 3.21M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.15B | 1.1B | 1.32B | 1.43B | 1.63B |
| Operating Income | 80.61M | 44.83M | 94.77M | 59.28M | 107.31M |
| Net Income | 14.76M | -14.84M | 24.73M | 10.65M | 3.04M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.69B | 2.69B | 2.97B | 3.23B | 3.28B |
| Total Liabilities | 1.89B | 1.88B | 1.89B | 2.14B | 2.16B |
| Total Equity | 796.16M | 813.36M | 1.08B | 1.09B | 1.12B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.65B | 1.79B | 2.06B | 2.43B | 2.69B |
| Total Liabilities | 1.41B | 1.53B | 1.71B | 1.94B | 1.88B |
| Total Equity | 233.14M | 258.3M | 346.16M | 491.45M | 813.36M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 131.94M | 220.86M | 17.09M | 133.09M | 190.49M |
| Investing | -152.82M | -201.47M | -60.94M | -138.28M | -184.26M |
| Financing | 231.1M | 195.64M | 228.3M | 404.4M | 400.07M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 104.32M | 233.76M | 149.49M | 146.42M | 220.86M |
| Investing | -99.47M | -126.24M | -221.51M | -246.95M | -201.47M |
| Financing | 24.95M | -45.56M | 104.67M | 93.65M | 195.64M |
| Market Cap | 4.54B |
| Price to Earnings Ratio | 1491.97 |
| Price to Sales Ratio | 2.78 |
| Price to Cash Ratio | 13.25 |
| Price to Book Ratio | 5.58 |
| Dividend Yield | - |
| Shares Outstanding | 74.03M |
| Average Volume (1 week) | 545.29k |
| Average Volume (1 Month) | 774.86k |
| 52 Week Change | 59.51% |
| 52 Week High | 93.65 |
| 52 Week Low | 36.47 |
| Spread (Intraday) | 0.8 (1.29%) |
| Company Name | RadNet Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.radnet.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
